Idibell

Scientists discover an epigenetic alteration in breast cancer that predicts lack of response to some chemotherapy treatments

Researchers from IDIBELL have collaborated on a study characterizes a protein called RBM38, key in the regulation of tumor cell death, which is disabled in breast tumors, making them more resistant to some chemotherapy treatments. Practical application Article’s reference

Scientists discover an epigenetic alteration in breast cancer that predicts lack of response to some chemotherapy treatments Read More »

Bioinformatics, systems biology and functional genomics, protagonists at IDIBELL

IDIBELL hosted DREAM, RECOMB and RICCI conferences on October 14 -19th On October 14 -19 IDIBELL has hosted the 6th Annual DREAM on Reverse Engineering Challenges, the 7th Annual RECOMB Satellite on Systems Biology and the 8th Annual RECOMB on Regulatory Genomics , which were first held outside the U.S.

Bioinformatics, systems biology and functional genomics, protagonists at IDIBELL Read More »

Playmancer project, awarded as the best European serious game on health

IDIBELL researchers and professionals of the Psychiatry Service of the Bellvitge University Hospital have been awarded the prize for best European serious game on health category for the therapeutic videogame: Playmancer. The award will be presented in the course of the Fun & Serious Game Festivalthat will take place on 8 and 9 November in

Playmancer project, awarded as the best European serious game on health Read More »

Colon tumor cells that metastasize to the liver become more aggressive in response to a new hostile microenvironment

Most malignant cells die; only survive those who adapt better Certain healthy liver cells promote an adaptive response in colorectal cancer cells by inhibiting proliferation and causing their death. Tumor cells, that adapt themselves to new conditions, change their behavior and morphology, favoring migration. Researchers from the IDIBELL and the Catalan Institute of Oncology (ICO), coordinated by David Garcia Molleví have published the results of this study in the journal Neoplasia . A hostile microenvironment Article’s reference

Colon tumor cells that metastasize to the liver become more aggressive in response to a new hostile microenvironment Read More »

IDIBELL and Cedars-Sinai join efforts for technology transfer

Cedars-Sinai Medical Center (Los Angeles) and IDIBELL have signed an agreement of cooperation on technology transfer. The agreement suppose the mutual support to increase technology transfer activities as well as access to the U.S. market for the commercialization of products or technologies developed by IDIBELL.

IDIBELL and Cedars-Sinai join efforts for technology transfer Read More »

Antonis Antoniou: “More than 1,500 users worldwide use Boadicea model to predict risk of breast cancer”

“Boadicea was the name of a British soldier who fought the Roman invasion. Now is also the name of a new tool to combat the new enemy: cancer.” The researcher of the University of Cambridge, Antonis Antoniou, explained at the IDIBELL seminar on 30 September his latest advances in the development of genetic models, such

Antonis Antoniou: “More than 1,500 users worldwide use Boadicea model to predict risk of breast cancer” Read More »

Scroll to Top